Cytomegalovirus IgG Control Serum BC109G

$94.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
Cytomegalovirus (CMV) IgG Control Serum
Applications: ELISA
IgG control serum
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC109G Categories: control serum, Virion/Serion kits Tags: Cytomegalovirus, ELISA control serum, IgG

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Cytomegalovirus reactive IgG
species reactivity	Cytomegalovirus
applications	ELISA
assay type	Indirect & quantitative
available size	3 mL

Cytomegalovirus IgG Control Serum BC109G

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Associated products Cytomegalovirus Avidity Reagent (B109AVID) Cytomegalovirus Antigen (BA109VS) Cytomegalovirus Avidity Control(BR109AVID) Cytomegalovirus Antigen (BA109VS) Cytomegalovirus IgG Control Serum (BC109G) Cytomegalovirus IgM Control Serum (BC109M) Cytomegalovirus IgG ELISA Kit (ESR109G) Cytomegalovirus IgM ELISA Kit (ESR109M)

target relevance

human antibody anti-Cytomegalovirus (CMV)

Cytomegalovirus (CMV)

Description
Virus that causes cytomegalovirus infection and congenital CMV disease

Structure
Cytomegalovirus (CMV), also known as Human herpesvirus 5 (HHV-5), is an enveloped, double-stranded DNA virus belonging to the genus Cytomegalovirus within the family Herpesviridae. The virus possesses an icosahedral capsid surrounded by a protein tegument and a lipid envelope containing multiple glycoproteins involved in host cell entry. CMV has one of the largest genomes among human viruses and is capable of infecting a wide variety of cell types including epithelial cells, endothelial cells, fibroblasts, monocytes, and leukocytes. Following primary infection, CMV establishes lifelong latency, primarily within cells of the myeloid lineage, and may periodically reactivate, particularly in immunocompromised individuals. CMV is widely distributed throughout the world, and a large proportion of adults show evidence of prior infection.

Diagnosis
The diagnosis of cytomegalovirus infection is performed through serological, molecular, and virological methods. Detection of CMV-specific IgM and IgG antibodies by ELISA or other immunoassays is commonly used to determine recent or past infection. Molecular methods such as quantitative polymerase chain reaction (PCR) are highly sensitive and are widely used to detect and monitor CMV DNA in blood, urine, saliva, cerebrospinal fluid, and other clinical specimens. Antigenemia assays and viral culture may also be employed in selected clinical settings. In pregnant women and immunocompromised patients, laboratory testing is particularly important for assessing active infection, viral load, and risk of disease progression.

Symptoms
Most cytomegalovirus infections in healthy individuals are asymptomatic or cause mild, self-limiting illness resembling infectious mononucleosis, characterized by fever, fatigue, malaise, sore throat, lymphadenopathy, and muscle aches. Following primary infection, the virus remains latent and may reactivate later in life. In immunocompromised individuals, including transplant recipients, cancer patients, and people with advanced HIV infection, CMV can cause severe disease involving the lungs, liver, gastrointestinal tract, retina, and central nervous system. Congenital CMV infection is a major cause of birth defects and may result in hearing loss, vision impairment, developmental delays, microcephaly, seizures, and other neurological complications. CMV remains one of the most significant opportunistic viral pathogens worldwide.

Data

FAQ & Publications

Frequently Asked Questions

What is the intended application of the Cytomegalovirus IgG Control Serum BC109G?

The Cytomegalovirus IgG Control Serum BC109G is designed for use as an IgG control serum in ELISA assays, specifically compatible with SERION ELISA classic and SERION ELISA antigen assays.

How should the Cytomegalovirus IgG Control Serum BC109G be stored to maintain its stability?

The Cytomegalovirus IgG Control Serum BC109G should be stored at temperatures between 2-8°C to ensure proper preservation and stability.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC109G protocol

Documents

#
CP0035	Safety Data Sheet	QC certificate

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Cytomegalovirus IgG Control Serum BC109G

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Aspergillus fumigatus IgG Control Serum BC132G

Echovirus IgG Control Serum BC135G

Adenovirus IgG Control Serum BC128G

Cytomegalovirus IgM Control Serum BC109M

Human Cytomegalovirus IgG Lateral flow dipstick kit 5572

Coxsackie IgG Virus Control Serum BC134G

Human Toxoplasma gondii, rubella virus, cytomegalovirus (CMV), and herpes simplex virus type 1 and 2 (HSV-1/2) IgG Lateral flow dipstick kit 6472

Chlamydia trachomatis IgG Control Serum BC1372G

ToRCH1/2 IgG Control Serum IC1701

Chlamydia pneumoniae IgG Control Serum BC1371G

Candida albicans IgG Control Serum BC117G

Campylobacter jejuni IgG Control Serum BC139G

Brucella IgG Control Serum BC116G

Borrelia burgdorferi IgG Control Serum BC121G

Bordetella pertussis IgG Control Serum BC120G